ICGEB and HCEMM Partner to Enhance Aging and Cancer Research

Strategic Insights -

The International Centre for Genetic Engineering and Biotechnology (ICGEB) and the Hungarian Centre of Excellence for Molecular Medicine (HCEMM) have solidified their partnership to tackle the complexities of aging and cancer, leveraging their combined expertise and infrastructure. This strategic collaboration will facilitate access to specialized platforms, including genomics and proteomics laboratories, advanced imaging facilities, and high-throughput screening technologies. By sharing their knowledge and resources, researchers will explore innovative approaches in cancer diagnostics, infectious diseases, immunology, and molecular modelling, ultimately driving the development of novel treatments and therapies.

Key Takeaways:

  • The partnership between ICGEB and HCEMM aims to strengthen research collaboration on aging and cancer by combining their strengths in international reach and translational medicine.
  • The collaboration spans multiple areas, including research, infrastructure, funding, and public engagement, with a focus on cancer diagnostics, infectious diseases, immunology, and molecular modelling.
  • Researchers will gain access to specialized platforms, including genomics and proteomics laboratories, advanced imaging facilities, and high-throughput screening technologies.
  • Initiatives will range from exploring genetic tumour signatures to developing novel immunotherapies and applying data-driven approaches in diagnostics.
  • The partnership includes coordinated applications for international and European research funding as well as joint public engagement initiatives to promote visibility through scientific forums and events.
  • Priority areas for future collaboration include diagnostics, biotechnology, and innovative health approaches.

Statistics:

  • Two years of strategic planning preceded the signing of the Memorandum of Understanding between ICGEB and HCEMM.
  • The partnership combines ICGEB's international reach with HCEMM's focus on translational medicine and age-related conditions.
  • The collaboration spans multiple areas, including research, infrastructure, funding, and public engagement.
  • Researchers will access specialized platforms, including:

+ Genomics and proteomics laboratories

+ Advanced imaging facilities

+ High-throughput screening technologies

Sources:

  • International Centre For Genetic Engineering & Biotechnology